The “Ozempic effect” has dominated headlines over the past year, impacting both healthcare and celebrity circles. Beyond these spheres,...

As we move into 2024, a key development in the M&A world is the Federal Trade Commission’s (FTC) proposed reform of the Hart-Scott-Rodino...

Do IPO’s and public listings continue to go hand in hand? In recent years, SPACs (Special Purpose Acquisition Companies) have emerged as...

December 2023 saw a significant surge in AI-related acquisitions, as established companies across sectors like biotech, legal, fintech,...

The year of 2023 has introduced a unique confluence of factors in M&A activity in the industrial sector that have significantly boosted...

The private equity sector in the United States is set for quite the resurgence following a period of contraction in 2023. A report by EY...

When one thinks of deal valuation what comes to mind? Is the image geared towards a quantitative framework consisting of a discounted...